Stock Analysis on Net

Stryker Corp. (NYSE:SYK)

This company has been moved to the archive! The financial data has not been updated since April 29, 2022.

Common Stock Valuation Ratios (Price Multiples)
Quarterly Data

Microsoft Excel

Historical Valuation Ratios (Summary)

Stryker Corp., historical price multiples (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Price to earnings (P/E) 45.28 47.65 52.83 48.64 69.46 57.72 43.23 45.35 31.33 39.24 23.72 22.60 19.64 18.96 48.55 58.86 62.59 54.36
Price to operating profit (P/OP) 35.47 36.77 39.93 36.20 47.78 41.52 31.40 33.20 24.04 30.13 32.94 33.22 27.96 26.55 23.52 25.45 27.41 24.21
Price to sales (P/S) 5.23 5.55 6.02 6.24 6.65 6.43 5.34 5.16 4.53 5.49 5.59 5.65 4.98 4.95 4.52 4.88 5.01 4.46
Price to book value (P/BV) 6.06 6.39 7.08 7.33 7.24 7.05 5.85 5.69 5.17 6.38 6.60 6.72 5.92 5.74 6.09 6.72 6.92 5.56 5.73 5.51 5.21

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Stryker Corp. P/E ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Stryker Corp. P/OP ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Stryker Corp. P/S ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return. Stryker Corp. P/BV ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.

Price to Earnings (P/E)

Stryker Corp., historical P/E calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
No. shares of common stock outstanding1 378,154,080 377,544,686 377,239,958 377,096,272 376,747,866 376,200,942 375,790,657 375,605,813 375,378,477 374,575,145 374,366,776 374,103,607 373,810,085 372,664,636 374,187,286 373,990,494 373,710,934 374,642,060 374,237,631 374,063,294 373,765,028
Selected Financial Data (US$)
Net earnings (loss) (in millions) 323 662 438 592 302 568 621 (83) 493 725 466 480 412 2,068 590 452 443 (249) 434 391 444
Earnings per share (EPS)2 5.33 5.28 5.04 5.52 3.74 4.25 4.67 4.26 5.76 5.56 9.15 9.49 9.42 9.53 3.30 2.89 2.73 2.72 0.00 0.00 0.00
Share price1, 3 241.26 251.65 266.07 268.68 259.58 245.34 202.01 193.30 180.62 218.24 217.09 214.45 185.04 180.75 160.38 169.98 170.67 148.01 159.74 147.80 135.37
Valuation Ratio
P/E ratio4 45.28 47.65 52.83 48.64 69.46 57.72 43.23 45.35 31.33 39.24 23.72 22.60 19.64 18.96 48.55 58.86 62.59 54.36
Benchmarks
P/E Ratio, Competitors5
Abbott Laboratories 25.48 29.13 31.42 33.80 36.79 48.49 58.45 58.36 45.61 41.83
Cigna Group 15.72 13.43 8.43 8.60 10.62 8.71 14.60 12.08 13.82 13.26
CVS Health Corp. 16.49 17.39 16.78 14.94 14.44 12.88 10.69 10.20 10.94 14.15
Elevance Health Inc. 20.46 18.13 18.65 22.10 19.99 15.87 14.35 11.97 14.80 15.96
Humana Inc. 18.48 18.34 22.09 22.82 15.20 14.48 13.49 15.26 19.09 18.10
Intuitive Surgical Inc. 55.10 59.94 71.86 69.15 89.95 87.47 82.17 70.73 44.27 48.72
Medtronic PLC 46.71 46.56 55.13 42.80 32.34 26.30 25.38 31.86 32.75 28.78
UnitedHealth Group Inc. 27.29 26.03 27.92 27.41 23.06 20.54 17.70 16.88 19.91 20.48

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Data adjusted for splits and stock dividends.

2 Q1 2022 Calculation
EPS = (Net earnings (loss)Q1 2022 + Net earnings (loss)Q4 2021 + Net earnings (loss)Q3 2021 + Net earnings (loss)Q2 2021) ÷ No. shares of common stock outstanding
= (323,000,000 + 662,000,000 + 438,000,000 + 592,000,000) ÷ 378,154,080 = 5.33

3 Closing price as at the filing date of Stryker Corp. Quarterly or Annual Report.

4 Q1 2022 Calculation
P/E ratio = Share price ÷ EPS
= 241.26 ÷ 5.33 = 45.28

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/E ratio The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings. Stryker Corp. P/E ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.

Price to Operating Profit (P/OP)

Stryker Corp., historical P/OP calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
No. shares of common stock outstanding1 378,154,080 377,544,686 377,239,958 377,096,272 376,747,866 376,200,942 375,790,657 375,605,813 375,378,477 374,575,145 374,366,776 374,103,607 373,810,085 372,664,636 374,187,286 373,990,494 373,710,934 374,642,060 374,237,631 374,063,294 373,765,028
Selected Financial Data (US$)
Operating income (loss) (in millions) 447 819 574 732 459 749 859 (20) 635 944 628 613 528 698 576 672 591 712 523 501 554
Operating profit per share2 6.80 6.84 6.66 7.42 5.43 5.91 6.43 5.82 7.51 7.24 6.59 6.46 6.62 6.81 6.82 6.68 6.23 6.11 0.00 0.00 0.00
Share price1, 3 241.26 251.65 266.07 268.68 259.58 245.34 202.01 193.30 180.62 218.24 217.09 214.45 185.04 180.75 160.38 169.98 170.67 148.01 159.74 147.80 135.37
Valuation Ratio
P/OP ratio4 35.47 36.77 39.93 36.20 47.78 41.52 31.40 33.20 24.04 30.13 32.94 33.22 27.96 26.55 23.52 25.45 27.41 24.21
Benchmarks
P/OP Ratio, Competitors5
Abbott Laboratories 21.33 24.45 26.84 29.01 31.39 40.69 45.82 45.19 35.87 34.03
Cigna Group 10.40 9.08 9.12 9.28 11.13 9.03 9.24 7.58 8.59 8.38
CVS Health Corp. 10.06 10.43 9.43 7.87 7.61 6.65 5.89 5.98 6.19 7.83
Elevance Health Inc. 17.53 15.70 15.81 19.93 15.79 12.10 10.93 9.03 11.95 13.55
Humana Inc. 17.45 17.08 21.55 14.39 11.02 9.78 9.84 11.28 14.59 15.35
Intuitive Surgical Inc. 49.98 56.11 67.95 69.51 89.18 88.37 83.88 71.30 43.68 48.89
Medtronic PLC 38.83 37.44 49.88 42.55 35.86 26.29 21.01 23.52 22.21 21.26
UnitedHealth Group Inc. 19.69 18.77 19.63 19.05 16.12 14.12 12.35 11.85 13.80 14.40

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Data adjusted for splits and stock dividends.

2 Q1 2022 Calculation
Operating profit per share = (Operating income (loss)Q1 2022 + Operating income (loss)Q4 2021 + Operating income (loss)Q3 2021 + Operating income (loss)Q2 2021) ÷ No. shares of common stock outstanding
= (447,000,000 + 819,000,000 + 574,000,000 + 732,000,000) ÷ 378,154,080 = 6.80

3 Closing price as at the filing date of Stryker Corp. Quarterly or Annual Report.

4 Q1 2022 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 241.26 ÷ 6.80 = 35.47

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/OP ratio Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit. Stryker Corp. P/OP ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.

Price to Sales (P/S)

Stryker Corp., historical P/S calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
No. shares of common stock outstanding1 378,154,080 377,544,686 377,239,958 377,096,272 376,747,866 376,200,942 375,790,657 375,605,813 375,378,477 374,575,145 374,366,776 374,103,607 373,810,085 372,664,636 374,187,286 373,990,494 373,710,934 374,642,060 374,237,631 374,063,294 373,765,028
Selected Financial Data (US$)
Net sales (in millions) 4,275 4,701 4,160 4,294 3,953 4,262 3,737 2,764 3,588 4,131 3,587 3,650 3,516 3,796 3,242 3,322 3,241 3,471 3,006 3,012 2,955
Sales per share2 46.09 45.31 44.19 43.08 39.06 38.15 37.84 37.46 39.84 39.74 38.86 37.97 37.12 36.50 35.48 34.87 34.06 33.22 0.00 0.00 0.00
Share price1, 3 241.26 251.65 266.07 268.68 259.58 245.34 202.01 193.30 180.62 218.24 217.09 214.45 185.04 180.75 160.38 169.98 170.67 148.01 159.74 147.80 135.37
Valuation Ratio
P/S ratio4 5.23 5.55 6.02 6.24 6.65 6.43 5.34 5.16 4.53 5.49 5.59 5.65 4.98 4.95 4.52 4.88 5.01 4.46
Benchmarks
P/S Ratio, Competitors5
Abbott Laboratories 4.42 4.78 5.38 5.36 5.64 6.30 6.13 5.77 5.09 4.83
Cigna Group 0.48 0.42 0.42 0.42 0.55 0.46 0.50 0.41 0.45 0.44
CVS Health Corp. 0.44 0.47 0.45 0.39 0.40 0.35 0.32 0.32 0.30 0.37
Elevance Health Inc. 0.89 0.81 0.78 0.73 0.76 0.60 0.61 0.63 0.65 0.74
Humana Inc. 0.65 0.65 0.73 0.71 0.73 0.64 0.76 0.76 0.74 0.76
Intuitive Surgical Inc. 15.34 17.89 22.12 21.73 23.19 21.29 20.09 18.44 13.33 15.01
Medtronic PLC 5.74 5.57 5.71 5.43 5.11 4.36 4.34 4.82 4.72 4.36
UnitedHealth Group Inc. 1.61 1.58 1.55 1.47 1.49 1.24 1.18 1.17 1.12 1.18

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Data adjusted for splits and stock dividends.

2 Q1 2022 Calculation
Sales per share = (Net salesQ1 2022 + Net salesQ4 2021 + Net salesQ3 2021 + Net salesQ2 2021) ÷ No. shares of common stock outstanding
= (4,275,000,000 + 4,701,000,000 + 4,160,000,000 + 4,294,000,000) ÷ 378,154,080 = 46.09

3 Closing price as at the filing date of Stryker Corp. Quarterly or Annual Report.

4 Q1 2022 Calculation
P/S ratio = Share price ÷ Sales per share
= 241.26 ÷ 46.09 = 5.23

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/S ratio An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative. Stryker Corp. P/S ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.

Price to Book Value (P/BV)

Stryker Corp., historical P/BV calculation (quarterly data)

Microsoft Excel
Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
No. shares of common stock outstanding1 378,154,080 377,544,686 377,239,958 377,096,272 376,747,866 376,200,942 375,790,657 375,605,813 375,378,477 374,575,145 374,366,776 374,103,607 373,810,085 372,664,636 374,187,286 373,990,494 373,710,934 374,642,060 374,237,631 374,063,294 373,765,028
Selected Financial Data (US$)
Total Stryker shareholders’ equity (in millions) 15,046 14,877 14,178 13,820 13,502 13,084 12,986 12,754 13,115 12,807 12,315 11,943 11,693 11,730 9,860 9,460 9,214 9,966 10,425 10,035 9,704
Book value per share (BVPS)2 39.79 39.40 37.58 36.65 35.84 34.78 34.56 33.96 34.94 34.19 32.90 31.92 31.28 31.48 26.35 25.29 24.66 26.60 27.86 26.83 25.96
Share price1, 3 241.26 251.65 266.07 268.68 259.58 245.34 202.01 193.30 180.62 218.24 217.09 214.45 185.04 180.75 160.38 169.98 170.67 148.01 159.74 147.80 135.37
Valuation Ratio
P/BV ratio4 6.06 6.39 7.08 7.33 7.24 7.05 5.85 5.69 5.17 6.38 6.60 6.72 5.92 5.74 6.09 6.72 6.92 5.56 5.73 5.51 5.21
Benchmarks
P/BV Ratio, Competitors5
Abbott Laboratories 5.56 5.75 6.61 6.38 6.27 6.65 6.30 5.94 5.40 4.96 4.65 4.86 4.49
Cigna Group 1.84 1.53 1.49 1.44 1.86 1.46 1.61 1.34 1.51 1.49 1.49 1.44 1.42
CVS Health Corp. 1.79 1.83 1.71 1.47 1.51 1.33 1.24 1.24 1.21 1.47 1.47 1.23 1.25
Elevance Health Inc. 3.55 3.07 2.88 2.67 2.78 2.19 2.10 2.06 2.23 2.42 2.13 2.40 2.15
Humana Inc. 3.66 3.34 3.63 3.82 3.99 3.55 3.55 3.71 4.04 4.07 3.48 3.38 3.07
Intuitive Surgical Inc. 7.48 8.59 10.64 10.35 10.40 9.53 9.35 9.19 7.22 8.13 8.43 8.49 8.68
Medtronic PLC 3.52 3.26 3.14 3.02 2.84 2.48 2.60 2.94 2.87 2.66 2.48 2.62 2.59
UnitedHealth Group Inc. 6.54 6.27 6.13 5.76 5.86 4.83 4.54 4.53 4.81 4.92 4.32 4.40 4.37

Based on: 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31).

1 Data adjusted for splits and stock dividends.

2 Q1 2022 Calculation
BVPS = Total Stryker shareholders’ equity ÷ No. shares of common stock outstanding
= 15,046,000,000 ÷ 378,154,080 = 39.79

3 Closing price as at the filing date of Stryker Corp. Quarterly or Annual Report.

4 Q1 2022 Calculation
P/BV ratio = Share price ÷ BVPS
= 241.26 ÷ 39.79 = 6.06

5 Click competitor name to see calculations.

Valuation ratio Description The company
P/BV ratio The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return. Stryker Corp. P/BV ratio decreased from Q3 2021 to Q4 2021 and from Q4 2021 to Q1 2022.